{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"isotretinoin","columns":[{"gene":"","key":"population-ba3c86150b510c03f036","label":"Isotretinoin syndrome","mondoId":"MONDO:0016467","onsetQualifier":null,"originColumnKey":"MONDO:0016467/ORPHA:2305","originalViews":[{"key":"MONDO:0016467/ORPHA:2305","label":"Isotretinoin syndrome","scopeLabel":"ORPHA:2305","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1fe089dfff813ea2f0c3b352b9ecc3b0883479f50d835d11407bf224ab57bb39","4a14c153daa8a486adeb87eaaacf810f47bda4e2a38d66e5902b6d1375f20c43","7cf35f6164308205a633ca9a38bedea431f03c0a7489f7cfb9cbae6973a0f7d5","863d414e9b5a4f273dc8fe17c4f4aefed3fd8799a9c521d9383abe08047f2fff","92af05671943b8b672acfd5c818d4d9889d769851dceaeb2e24d43487fef84fc","94e7b55d7642f8d3dbea59b0f0f375b61ccb13d7f2e77190466f7df6b129316d","bb1d3b1494dd60732b617b9d211c8111b5d7b31786cc2cb1f01f8eb1587566b3","c8d7a185209a5e672eb4700f40e9b86e97b5b6e5a13516196a61bff7e08ad177","ef1faddaa79f061650774f32fd5e1a7474824731097d8ac6551907526ec6086a","f4514614c55ad4704a5376a4e711bcda8625710a2cf71c625bdb170f983cf9eb","f903167e1a101fb7c93e758d6a5c4bdc59fa2e7683aa022c93ed414ff057545a","f90e2c9c4a72ac517b787a88be90aef2c01a8b15807f1e9659c47fad1e390ef6"],"recordQualifiers":{},"scopeLabel":"ORPHA:2305","sourceIds":["ORPHA:2305"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ba3c86150b510c03f036"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000356","HP:0004422","HP:0000175","HP:0100543","HP:0005280","HP:0001315","HP:0001800"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"orphanet":12}},"features":[{"hpoId":"HP:0000356","label":"Abnormality of the outer ear","primary":true},{"hpoId":"HP:0004422","label":"Biparietal narrowing","primary":true},{"hpoId":"HP:0000175","label":"Cleft palate","primary":true},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":true},{"hpoId":"HP:0005280","label":"Depressed nasal bridge","primary":true},{"hpoId":"HP:0001315","label":"Diminished deep tendon reflex","primary":true},{"hpoId":"HP:0001800","label":"Hypoplastic toenails","primary":true},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0000347","label":"Micrognathia","primary":false},{"hpoId":"HP:0008551","label":"Microtia","primary":false},{"hpoId":"HP:0000960","label":"Sacral dimple","primary":false},{"hpoId":"HP:0003298","label":"Spina bifida occulta","primary":false}],"ledeHtml":"Isotretinoin embryopathy is an association of malformations caused by the teratogenic effect of isotretinoin, an oral synthetic vitamin A derivative, which is used to treat severe recalcitrant cystic acne. Exposure to isotretinoin during the first trimester of pregnancy has been associated with an increased risk of spontaneous abortions and severe birth defects including serious craniofacial (microcephaly, asymmetric crying facies, microphthalmia, developmental abnormalities of the external ear, ocular hypertelorism), cardio vascular (conotruncal heart defects, aortic arch abnormalities), and central nervous system (hydrocephalus, microcephaly, lissencephaly, Dandy-Walker malformation, cognitive deficit) anomalies and thymic aplasia. Isoretinoin is contraindicated during pregnancy.","mondoId":"MONDO:0016467","node":{"canonicalSlug":"isotretinoin","comparisons":[{"documentSha256":"3dae2e68d1fabbe83afc6fa755c13476c9788d54e7a052195c7f085a328e6fb2","key":"legacy-isotretinoin-like","kind":"legacy","label":"isotretinoin-like syndrome","memberIds":["MONDO:0009473","MONDO:0016467"],"mondoId":"MONDO:0009473","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/isotretinoin-like.3dae2e68d1fabbe83afc6fa755c13476c9788d54e7a052195c7f085a328e6fb2.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"isotretinoin syndrome","paragraphs":["Isotretinoin embryopathy is an association of malformations caused by the teratogenic effect of isotretinoin, an oral synthetic vitamin A derivative, which is used to treat severe recalcitrant cystic acne. Exposure to isotretinoin during the first trimester of pregnancy has been associated with an increased risk of spontaneous abortions and severe birth defects including serious craniofacial (microcephaly, asymmetric crying facies, microphthalmia, developmental abnormalities of the external ear, ocular hypertelorism), cardio vascular (conotruncal heart defects, aortic arch abnormalities), and central nervous system (hydrocephalus, microcephaly, lissencephaly, Dandy-Walker malformation, cognitive deficit) anomalies and thymic aplasia. Isoretinoin is contraindicated during pregnancy."],"scope":"exact","source":"MONDO","upstream":"Orphanet:2305","url":"https://monarchinitiative.org/MONDO:0016467"},"ownColumnKeys":["population-ba3c86150b510c03f036"],"publication":"published","relationships":[{"kind":"parent","label":"syndromic disease","mondoId":"MONDO:0002254","slug":null},{"kind":"parent","label":"isotretinoin-like syndrome","mondoId":"MONDO:0009473","slug":"isotretinoin-like"},{"kind":"parent","label":"toxic or drug-related embryofetopathy","mondoId":"MONDO:0016677","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"1fe089dfff813ea2f0c3b352b9ecc3b0883479f50d835d11407bf224ab57bb39","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008551","is_excluded":false,"label":"Microtia","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4a14c153daa8a486adeb87eaaacf810f47bda4e2a38d66e5902b6d1375f20c43","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005280","is_excluded":false,"label":"Depressed nasal bridge","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7cf35f6164308205a633ca9a38bedea431f03c0a7489f7cfb9cbae6973a0f7d5","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004422","is_excluded":false,"label":"Biparietal narrowing","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"863d414e9b5a4f273dc8fe17c4f4aefed3fd8799a9c521d9383abe08047f2fff","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001800","is_excluded":false,"label":"Hypoplastic toenails","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"92af05671943b8b672acfd5c818d4d9889d769851dceaeb2e24d43487fef84fc","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000175","is_excluded":false,"label":"Cleft palate","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"94e7b55d7642f8d3dbea59b0f0f375b61ccb13d7f2e77190466f7df6b129316d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003298","is_excluded":false,"label":"Spina bifida occulta","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bb1d3b1494dd60732b617b9d211c8111b5d7b31786cc2cb1f01f8eb1587566b3","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000347","is_excluded":false,"label":"Micrognathia","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c8d7a185209a5e672eb4700f40e9b86e97b5b6e5a13516196a61bff7e08ad177","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ef1faddaa79f061650774f32fd5e1a7474824731097d8ac6551907526ec6086a","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000356","is_excluded":false,"label":"Abnormality of the outer ear","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f4514614c55ad4704a5376a4e711bcda8625710a2cf71c625bdb170f983cf9eb","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000960","is_excluded":false,"label":"Sacral dimple","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f903167e1a101fb7c93e758d6a5c4bdc59fa2e7683aa022c93ed414ff057545a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001315","is_excluded":false,"label":"Diminished deep tendon reflex","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f90e2c9c4a72ac517b787a88be90aef2c01a8b15807f1e9659c47fad1e390ef6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2305","disease_name":"Isotretinoin syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"ORPHA:2305","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016467\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:2305</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Isotretinoin embryopathy is an association of malformations caused by the teratogenic effect of isotretinoin, an oral synthetic vitamin A derivative, which is used to treat severe recalcitrant cystic acne. Exposure to isotretinoin during the first trimester of pregnancy has been associated with an increased risk of spontaneous abortions and severe birth defects including serious craniofacial (microcephaly, asymmetric crying facies, microphthalmia, developmental abnormalities of the external ear, ocular hypertelorism), cardio vascular (conotruncal heart defects, aortic arch abnormalities), and central nervous system (hydrocephalus, microcephaly, lissencephaly, Dandy-Walker malformation, cognitive deficit) anomalies and thymic aplasia. Isoretinoin is contraindicated during pregnancy.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016467\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"isotretinoin","sourceDocuments":[{"name":"MONDO: isotretinoin syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0016467"}],"sourceNote":"","synonyms":["Accutane fetal effects of","Accutane foetal effects of","Accutane-exposed pregnancies","Acutane embryopathy","fetal isotretinoin syndrome","Fetal Retinoid Syndrome","fetal retinoid syndrome","foetal isotretinoin syndrome","foetal retinoid syndrome","Isotretinoin (RoAccutane) embryopathy","Isotretinoin embryopathy","Isotretinoin fetal effects of","Isotretinoin foetal effects of","Isotretinoin teratogen syndrome","retinoic acid embryopathy","Retinoids embryopathy"],"takeawayHtml":"","title":"isotretinoin syndrome"},"schemaVersion":1}
